Cannabis and Psilocybin Mushrooms – Two Very Similar Situations Are psilocybin mushrooms (aka “magic mushrooms”) the next cannabis? Lately, this question has become more prevalent for a variety of reasons. …
Oregon Psilocybin Society – Two Key Points On October 20, 2018, the Oregon Psilocybin Society (“OPS”) hosted a meeting about “The Science of Psilocybin” at Taborspace in Portland, Oregon. The meeting …
Psilocybin Cocktail Found in Insects Researchers at West Virginia University have discovered the first evidence of psilocybin within the animal kingdom. The Kasson Group at West Virginia University found psilocybin and …
Pharmaceutical Interest in Psilocybin Pharmaceutical interest in psilocybin appears to be increasing. As of September 1st, 2018, eighteen clinical trials with psilocybin have been completed. See Global Data Clinical Trials Database. Twenty one …
FDA Approves COMPASS Pathways’s Psilocybin Clinical Trials The United States Food and Drug Administration (FDA) has approved COMPASS Pathways’s clinical trials using psilocybin for treating depression, namely “Treatment Resistant Depression” …
Entourage Effect – Synergistic Combinations of Active Ingredients Magic mushrooms contain multiple active ingredients, collectively called “psilocybin derivatives.” These molecules work together to create an “entourage” of psychoactive (and non-psychoactive) effects …
Bluing Reaction – Request for Proposals Bluing (or blue bruising) is one of the most famous features of psilocybin-containing mushrooms, aka “magic mushrooms.” See article on bluing reaction. In short, “magic mushrooms” …
Microdosing Study by Petranker and Anderson Newsweek magazine just published an article about microdosing psychedelics (e.g., psilocybin mushrooms, LSD, etc.). The article reported a “new study” conducted by a “team …
Interviews with Michael Pollan Previously we wrote about Michael Pollan’s latest book How to Change Your Mind. Since the release of that work, Michael Pollan has earned considerable attention from …
COMPASS Pathways Targeting “Patient Access” to Synthetic Psilocybin COMPASS Pathways is a life sciences company, founded in 2016, to “accelerate patient access to evidence-based innovation in mental health.” According to their …
